Literature DB >> 9535887

Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system.

T Wakita1, C Taya, A Katsume, J Kato, H Yonekawa, Y Kanegae, I Saito, Y Hayashi, M Koike, M Kohara.   

Abstract

Conditional gene expression has greatly facilitated the examination of the functions of particular gene products. Using the Cre/loxP system, we developed efficient conditional transgene activation of hepatitis C virus (HCV) cDNA (nucleotides 294-3435) in transgenic mice. Efficient recombination was observed in transgenic mouse liver upon intravenous administration of adenovirus that expresses Cre DNA recombinase. After transgene activation, most hepatocytes were stained with anti-core polyclonal antibody, and 21-, 37-, and 64-kDa proteins were detected by Western blot analysis in liver lysates using anti-core, E1, and E2 monoclonal antibodies, respectively. Serum core protein was detected in transgenic mice 7 days after transgene activation with concurrent increases in serum alanine aminotransferase levels. Subsequently, an anti-core antibody response was detected 14 days after infection. Furthermore, a CD4 and CD8 positive cell depletion assay normalized both the serum alanine aminotransferase increases and pathological changes in the liver. These results suggest that HCV proteins are not directly cytopathic and that the host immune response plays a pivotal role in HCV infection. Thus, this HCV cDNA transgenic mouse provides a powerful tool with which to investigate the immune responses and pathogenesis of HCV infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9535887     DOI: 10.1074/jbc.273.15.9001

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Efficient gene activation in cultured mammalian cells mediated by FLP recombinase-expressing recombinant adenovirus.

Authors:  M Nakano; K Odaka; M Ishimura; S Kondo; N Tachikawa; J Chiba; Y Kanegae; I Saito
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

2.  Simultaneous on/off regulation of transgenes located on a mammalian chromosome with Cre-expressing adenovirus and a mutant loxP.

Authors:  Saki Kondo; Aya Okuda; Hiromi Sato; Naoto Tachikawa; Miho Terashima; Yumi Kanegae; Izumu Saito
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

Review 3.  Gene targeting in mice: a review.

Authors:  Hicham Bouabe; Klaus Okkenhaug
Journal:  Methods Mol Biol       Date:  2013

Review 4.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 5.  Recent advances in the development of new transgenic animal technology.

Authors:  Xiangyang Miao
Journal:  Cell Mol Life Sci       Date:  2012-07-26       Impact factor: 9.261

6.  Longitudinal evaluation of the structure of replicating and circulating hepatitis C virus quasispecies in nonprogressive chronic hepatitis C patients.

Authors:  B Cabot; M Martell; J I Esteban; M Piron; T Otero; R Esteban; J Guardia; J Gómez
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

7.  Aberrant transcription and post-transcriptional processing of hepatitis C virus non-structural genes in transgenic mice.

Authors:  Mayura M Desai; Batbayar Tumurbataar; Yueqing Zhang; Lee-Nien Lillian Chan; Jiaren Sun; Teh-Sheng Chan
Journal:  Transgenic Res       Date:  2011-02-24       Impact factor: 2.788

Review 8.  Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies.

Authors:  Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

Review 9.  Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer.

Authors:  David R McGivern; Stanley M Lemon
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

10.  A method for the generation of conditional gene repair mutations in mice.

Authors:  I Dragatsis; S Zeitlin
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.